425: Runway Growth to Acquire SWK Holdings in $220M Deal

Runway Growth Finance Corp. announced a definitive merger agreement to acquire SWK Holdings Corporation for approximately $220 million, significantly expanding its healthcare and life sciences portfolio.

Summary

• Runway Growth Finance Corp. (RWAY) has entered into a definitive merger agreement to acquire SWK Holdings Corporation (SWKH), a life science focused specialty finance company.
• The transaction is structured as a net asset value (NAV)-for-NAV merger, with an estimated purchase price of approximately $220 million.
• Consideration includes a fixed stock component of $75.5 million in Runway Growth shares and approximately $145 million in cash.
• Runway Growth Capital LLC, RWAY's external investment adviser, will contribute an additional $9 million in cash for distribution to SWK stockholders.
• The acquisition is expected to increase Runway Growth's total assets to $1.3 billion pro forma and expand its healthcare investments from 14% to approximately 31% of its portfolio.
• The merger is anticipated to be mid-single-digit accretive to Runway Growth's net investment income (NII) during the first full quarter post-close.
• SWK's portfolio comprises 22 companies with an approximate fair value of $242 million as of August 15, 2025.
• The transaction has been unanimously approved by SWK's Board of Directors and is supported by Carlson Capital L.P. through a Voting Agreement.
• Closing is expected in late 2025 or the first quarter of 2026, subject to SWK shareholder and regulatory approvals, and other customary closing conditions.

Sentiment

Score: 9

Explanation: The filing presents a highly positive outlook, detailing a strategic acquisition expected to be accretive to Net Investment Income, significantly expand asset base, and enhance market position in a key growth sector. Management commentary reinforces strong confidence in the transaction's benefits and future growth prospects.

Positives

• Expected mid-single-digit run-rate Net Investment Income (NII) accretion during the first full quarter following the transaction close.
• Expansion of Runway Growth's balance sheet to $1.3 billion in total assets pro forma, enhancing scale and diversification.
• Increased exposure to the high-growth healthcare and life sciences sector, with healthcare investments rising from 14% to approximately 31% of the portfolio.
• Addition of SWK's healthcare and life sciences investment and deal sourcing teams to Runway Growth Capital.
• Anticipated improvements in dividend coverage and Return on Equity (ROE) for Runway Growth.
• Broadening of Runway Growth's shareholder base and increased trading liquidity of common shares through the issuance of $75.5 million in Runway Growth shares to SWK shareholders.
• Reinforces Runway Growth's strategy to diversify and optimize its portfolio with high-quality investments.
• Positions Runway Growth for future organic and inorganic growth strategies, supported by the BC Partners Credit platform.

Risks

• Ability of the parties to consummate the mergers on the expected timeline, or at all.
• Uncertainty regarding the expected synergies and savings associated with the mergers.
• Ability to realize the anticipated benefits of the mergers, including the expected elimination of certain expenses and costs.
• The percentage of SWK's stockholders voting in favor of the transaction.
• Possibility that competing offers or acquisition proposals will be made.
• Possibility that any or all of the various conditions to the consummation of the mergers may not be satisfied or waived.
• Risks related to diverting management's attention from ongoing business operations.
• Uncertainty regarding the combined company's plans, expectations, objectives, and intentions as a result of the mergers.
• Any potential termination of the merger agreement.
• Uncertainty regarding the future operating results and net investment income projections of the combined company.
• The ability of Runway Growth Capital LLC and its affiliates to attract and retain highly talented professionals.
• Uncertainty regarding the business prospects of the combined company and the prospects of its portfolio companies.
• The impact of the investments that the combined company expects to make.
• The ability of the portfolio companies of the combined company to achieve their objectives.
• The expected financings and investments and additional leverage that the combined company may seek to incur in the future.
• The adequacy of the cash resources and working capital of the combined company.
• The timing of cash flows, if any, from the operations of the portfolio companies of the combined company.
• The risk that stockholder litigation in connection with the mergers may result in significant costs of defense and liability.
• Future changes in laws or regulations (including the interpretation of these laws and regulations by regulatory authorities).
• The impact of the merger on the depth of trading in Runway Growth's shares of common stock post-closing.
• Risks associated with the research and development of medical products, which involve a high degree of risk and a small number of programs resulting in commercialization.

Future Outlook

Runway Growth Finance Corp. anticipates that the acquisition of SWK Holdings will significantly advance its strategy to diversify and optimize its portfolio, particularly in the healthcare and life sciences sectors. The combined entity expects to enhance its earnings power, achieve mid-single-digit Net Investment Income (NII) accretion, and expand its total assets to $1.3 billion. Supported by the BC Partners Credit platform, Runway Growth plans to pursue both organic and inorganic growth strategies, aiming to generate long-term shareholder value through disciplined venture debt investing and a focus on excellent credit quality.

Management Comments

• David Spreng, Runway Growth's Founder and CEO, stated: "This transaction meaningfully advances our strategy to diversify and optimize our portfolio by adding SWK’s high-quality investments in the key sectors of healthcare and life sciences. At the same time, we are enhancing our earnings power, more than offsetting the anticipated loan repayments we previously signaled, and we expect to deliver mid-single-digit NII accretion."
• David Spreng also commented: "This transaction reinforces the strength of Runway Growth’s portfolio as we work to generate long-term value for our shareholders through disciplined growth and venture debt investing with a focus on excellent credit quality in the sectors we know best. Looking ahead, and with the full support of BC Partners Advisors L.P., we are pursuing growth through both organic and inorganic strategies as a permanent capital vehicle backed by the $10 billion BC Partners Credit platform. We are doing all of this while growing our shareholder base, improving our existing robust portfolio metrics and increasing our total assets to $1.3 billion pro forma with the SWK merger transaction."

Industry Context

This acquisition positions Runway Growth Finance Corp. to significantly strengthen its presence in the specialty finance market, particularly within the high-growth healthcare and life sciences sectors. The move aligns with broader industry trends of consolidation and specialization, allowing Runway Growth to leverage SWK's expertise and portfolio to become a more dominant player in providing non-dilutive financing to commercial-stage healthcare companies. The backing of the BC Partners Credit platform further enhances its competitive advantage and capacity for future strategic growth.

Stakeholder Impact

• Shareholders of SWK Holdings Corporation will receive consideration in the form of Runway Growth shares and cash, potentially benefiting from the combined entity's enhanced financial profile.
• Shareholders of Runway Growth Finance Corp. are expected to benefit from Net Investment Income (NII) accretion, increased asset scale, portfolio diversification, and improved dividend coverage and ROE.
• Employees of SWK's healthcare and life sciences teams will be integrated into Runway Growth Capital's investment and deal sourcing teams, indicating potential employment continuity and expanded opportunities.
• Portfolio companies of both entities may benefit from the combined company's larger capital base and expanded expertise in specialty finance.

Next Steps

• SWK Holdings Corporation stockholders will need to approve the transaction.
• Regulatory approvals must be obtained.
• Other customary closing conditions must be satisfied.
• Runway Growth will file a registration statement on Form N-14, containing a preliminary proxy statement/prospectus.
• A definitive proxy statement/prospectus will be mailed to SWK stockholders after the Registration Statement is declared effective.
• A conference call will be held on October 10, 2025, to discuss the transaction.

Key Dates

Recommendation

The acquisition is expected to be mid-single-digit accretive to Net Investment Income (NII), significantly expands Runway Growth's total assets to $1.3 billion, and diversifies its portfolio into the high-growth healthcare and life sciences sectors. This strategic move, supported by the BC Partners Credit platform, enhances the company's financial profile, improves dividend coverage, and positions it for sustained organic and inorganic growth, making it an attractive investment.

Keywords

Runway Growth Finance, SWK Holdings, Merger, Acquisition, Healthcare Finance, Life Sciences, Specialty Finance, Venture Debt, BDC, Investment